Product Program year 2025 Source: CMS Open Payments

Coumadin

Drug Cardiovascular

NDC 0056-0189-90

Open in the dashboard

General payments

$724

46 payments

Research payments

$0

0 payments

Through program year 2025, $724 in general payments and $0 in research payments were reported against Coumadin (Cardiovascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $404 26
2024 General $171 10
2023 General $131 9
2021 General $19 1

Breakdown

Who paid General payments · program years 2021–2025
  1. E.R. Squibb & Sons, L.L.C. $724 46 payments
Top recipients General payments · program year 2025
  1. Andre Desire Cardiovascular Disease · Wichita Falls, TX $33 8% · 2 payments
  2. Fardin Djafari Cardiovascular Disease · Wichita Falls, TX $33 8% · 2 payments
  3. Vedampattu Ganeshram Cardiovascular Disease · Wichita Falls, TX $33 8% · 2 payments
  4. Karla Dwyer Nurse Practitioner, Gerontology · Wichita Falls, TX $33 8% · 2 payments
  5. Jacqueline Berend Nurse Practitioner · Wichita Falls, TX $33 8% · 2 payments

The top 5 of 19 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Psychiatry Psychiatry & Neurology $122 32% · 7 practitioners
  2. Cardiovascular Disease Internal Medicine $99 26% · 3 practitioners
  3. Nurse Practitioner, Psychiatric/Mental Health Nurse Practitioner $59 16% · 4 practitioners
  4. Nurse Practitioner $40 11% · 2 practitioners
  5. Nurse Practitioner, Gerontology Nurse Practitioner $33 9% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $166 41% · 5 recipients
  2. Florida $129 32% · 6 recipients
  3. New York $74 18% · 4 recipients
  4. Indiana $14 4% · 1 recipient
  5. Kentucky $14 3% · 2 recipients

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

46 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record